Brief: Galapagos Cuts Jyseleca FY Sales Guidance

Lakefront Biotherapeutics NV

04/08/2023 08:39

Aug 4 (Reuters) - GALAPAGOS  GLPG.AS :
    * REPORTED ON THURSDAY H1 NET PROFIT EUR 28.3 MLN VS LOSS
EUR 32.3
MLN YR AGO
    * H1 OPERATING PROFIT EUR 11.3 MLN VS LOSS EUR 97.5 MLN YR
AGO
    * H1 TOTAL NET REVENUES EUR 328.8 MLN VS EUR 274.0 MLN YR
AGO
    * CASH AND CURRENT FINANCIAL INVESTMENTS OF EUR 3.9 BILLION
ON 30
JUNE 2023
    * H1 JYSELECA NET SALES OF EUR 54.3 MILLION
    * FULL YEAR 2023 NET SALES GUIDANCE FOR JYSELECA LOWERED TO
BETWEEN EUR 100 MLN AND EUR 120 MLN
    * 2023 CASH BURN GUIDANCE OF between EUR 380 MLN AND EUR 420
MLN
REITERATED

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNE9NwyYj
 Further company coverage:  GLPG.AS  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))